Alzheimer's May Start With Protein Hijacking, Not Just Plaque Buildup
UC Riverside researchers show amyloid beta may displace tau from neurons, triggering brain cell breakdown before plaques even form.
Alzheimer's disease research, amyloid plaques, tau tangles, and cognitive decline
410 articles
UC Riverside researchers show amyloid beta may displace tau from neurons, triggering brain cell breakdown before plaques even form.
The SenNet atlas reveals where aging cells accumulate in human tissues, opening new doors for senolytic therapies and healthspan extension.
A completed University of Kansas trial investigates whether creatine monohydrate can support brain energy metabolism in Alzheimer's patients.
A completed Mount Sinai RCT tested whether HBOT can improve brain blood flow and cognition in diabetic elders with mild cognitive impairment.
A Phase 1 trial of AV-1959R, an Aβ-targeting vaccine, tests safety and antibody generation in healthy adults aged 40–60.
A first-in-human multiple-ascending-dose trial tests Contraloid, an oral peptide designed to disassemble toxic amyloid-beta oligomers linked to Alzheimer's disease.
DNA methylation biomarkers from a simple blood test may track cognitive aging and neurological disease risk with unprecedented precision.
Machine learning models trained on acoustic speech features from routine primary care conversations identified cognitive impairment with meaningful accuracy.
A 4-year Kyoto University study found older adults who kept playing instruments preserved memory and lost less brain gray matter.
A 3-year UT Dallas study of nearly 4,000 adults found measurable brain health gains at every age — even in your 80s and 90s.
A completed trial tests whether daily Nordic berry beverages can sharpen cognition in healthy adults over 12 weeks.
Exercise triggers skeletal muscle to release tiny vesicles that travel to the brain and help microglia clear amyloid plaques in Alzheimer's mice.